Associations in tumor infiltrating lymphocytes between clinicopathological factors and clinical outcomes in estrogen receptor‑positive/human epidermal growth factor receptor type 2 negative breast cancer
Work
Year: 2018
Type: article
Abstract: The value of assessing tumor infiltrating lymphocytes (TILs) in estrogen receptor (ER) positive/human epidermal growth factor receptor type 2 (HER2) negative breast cancer has yet to be determined. In... more
Source: Oncology Letters
Institutions Okayama University Hospital, Japanese Foundation For Cancer Research, Hokkaido University Hospital, Juntendo University, Osaka National Hospital +3 more
Cites: 49
Cited by: 36
Related to: 10
FWCI: 1.892
Citation percentile (by year/subfield): 88.35
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: gold